C16H20N2

C16H20N2 is a chemical compound that serves as the chemical name for the substance known as Methylphenidate. It is a central nervous system stimulant commonly used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. The compound is classified as a psychostimulant and is a Schedule II controlled substance in the United States due to its potential for abuse and dependence.

Methylphenidate is a racemic compound, consisting of equal parts of the D-isomer and L-isomer of the compound. The chemical structure of C16H20N2 involves a combination of methyl and phenyl groups, which contribute to its stimulant properties. The compound functions by inhibiting the reuptake of dopamine and norepinephrine in the brain, resulting in increased levels of these neurotransmitters and enhanced alertness and focus in individuals with ADHD.

C16H20N2 is available in various formulations, including oral tablets and extended-release capsules, and is often prescribed in combination with other medications to manage symptoms of ADHD and other conditions. However, its use is restricted due to concerns of diversion and misuse, as well as potential side effects such as insomnia, anxiety, and cardiovascular problems.

Research into C16H20N2 has focused on its neuropharmacological mechanisms and potential therapeutic applications beyond ADHD and narcolepsy. Studies have explored its effects on cognitive function, sleep disorders, and substance use disorders, highlighting its complex pharmacological profile and the need for further investigation into its therapeutic potential.